Link Pharma Chem Q1 FY27 Unaudited Financial Results Approved by Board
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 05 Aug 2026, 02:19 PM IST · BSE ID: 9a5e1a1e-2838-491d-bb2b-e2535872f14b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial report for the last quarter, showing Rs. 876.84 million in sales.
🤖 AI Summary
- Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026.
- Revenue from operations reached Rs. 876.84 million for the first quarter of FY27.
- Profit before tax stood at Rs. 38.87 million for the quarter ended June 30, 2026.
- Total comprehensive income for the quarter was reported as Rs. 37.03 million.
- Earnings per equity share for Q1 FY27 were Rs. 0.72 (not annualised).
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q1 FY27)
876.84 million
12.20
Profit before tax (Q1 FY27)
38.87 million
-23.83
Total comprehensive income (Q1 FY27)
37.03 million
-27.14
Earnings per equity share (Q1 FY27)
0.72 Rs.
-20.88
🏢 How This Affects the Company
The company's core business, 'Manufacture and Sale of Chemicals,' generated Rs. 876.84 million in revenue from operations for the quarter.
Profit before tax was Rs. 38.87 million, with a reported total comprehensive income of Rs. 37.03 million for Q1 FY27.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this financial results disclosure.
👤
Who Is Affected
All shareholders are affected as these results provide an update on the company's financial performance, specifically showing quarterly revenue and profitability figures.
🔍
Management Signal
The approval of unaudited results indicates management's adherence to regulatory disclosure requirements for quarterly financial reporting.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — verify revenue and profitability trends.
Any further disclosures on operational efficiencies or cost management initiatives.
Updates regarding the 'Manufacture and Sale of Chemicals' segment performance.
LOW RISK
The filing is a standard quarterly financial results disclosure.
💡 Investor Takeaway
Link Pharma Chem Ltd. reported Q1 FY27 revenue from operations of Rs. 876.84 million, up from Rs. 781.48 million in Q1 FY26. Profit before tax was Rs. 38.87 million, lower than Rs. 50.97 million in Q1 FY26, with basic EPS at Rs. 0.72.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations increased to Rs. 876.84 million in Q1 FY27 from Rs. 781.48 million in Q1 FY26.
- Profit before tax for Q1 FY27 was Rs. 38.87 million, recovering from a loss before tax of Rs. (49.00) million in Q4 FY26.
⚠️ Concerns
- Profit before tax of Rs. 38.87 million in Q1 FY27 is lower than Rs. 50.97 million reported in Q1 FY26.
- Basic and diluted earnings per share decreased to Rs. 0.72 in Q1 FY27 from Rs. 0.91 in Q1 FY26.
📅 Company Track Record
Link Pharma Chem Ltd. previously informed BSE on July 28, 2026, about the Board meeting scheduled for August 05, 2026, to approve the Q1 FY27 unaudited financial results.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Link Pharma Chem Ltd.'s revenue from operations for the quarter ended June 30, 2026?
Link Pharma Chem Ltd. reported revenue from operations of Rs. 876.84 million for the quarter ended June 30, 2026.
What was the profit before tax for Link Pharma Chem Ltd. in Q1 FY27?
The profit before tax for Link Pharma Chem Ltd. for the quarter ended June 30, 2026, was Rs. 38.87 million.
What were the earnings per equity share for Link Pharma Chem Ltd. in Q1 FY27?
Basic and diluted earnings per equity share for Link Pharma Chem Ltd. for the quarter ended June 30, 2026, were Rs. 0.72.
How did Q1 FY27 revenue compare to Q1 FY26 for Link Pharma Chem Ltd.?
Revenue from operations in Q1 FY27 was Rs. 876.84 million, compared to Rs. 781.48 million in Q1 FY26.
What was the total comprehensive income for Link Pharma Chem Ltd. in Q1 FY27?
Total comprehensive income for Link Pharma Chem Ltd. for the quarter ended June 30, 2026, was Rs. 37.03 million.
Questions based on this BSE filing only. For information purposes.